News and price dashboard

Datavault AI jumps on two 8-K filings

Datavault AI is up 12.3%, the largest move on the list. Two 8-K filings landed the same day: one covering officer and director changes plus compensatory arrangements and a Regulation FD disclosure, the other reporting entry into a material definitive agreement. Both are headline-only here, so the substance of the agreement and who is coming or going isn't visible from what I have. The third DVLT item is a TradingView chart post from a retail author calling for a move above $0.40 to $1.00 off a wave pattern, not company news.

Vicor and the AI infrastructure financing selloff

Vicor is down 10.4%, and GuruFocus ties the drop to worries about the cost of financing AI infrastructure buildout. Recent government reports showed hotter-than-expected consumer and wholesale inflation, raising fears that rates stay high enough to squeeze capital-intensive data centre projects. Vicor makes modular power components for data centres, telecoms, aerospace and EVs, with a $10.08bn market cap. GuruFocus puts the stock at $218.67 against a GF Value of $72.10, a 203% premium, a trailing P/E of 70.2x versus a five-year median of 74.21x, and a GF Score of 81 with valuation scored 1 out of 10. Insiders sold $424.1m over the past year with no buying, and six of seven tracked gurus trimmed. The same article names Vertiv and nVent as falling alongside it, and Vertiv does appear separately on your list down 3.6%, with Mizuho cutting its target to $280 and GuruFocus flagging a GF Value of $179.56 against a $214.75 price. Arista is down 5.0% and Coherent 4.8%, both headline-only, and the TSMC and Micron items include a GuruFocus piece headlined on chip stocks falling on inflation concerns and an Investor's Business Daily headline on chips tumbling on AI investment worries. That's the connective thread running through much of today's red.

TeraWulf up on the AI data centre story

TeraWulf is up 9.4%. The only item is a TradingView long write-up, not company news, but it lays out the contracted position: a 20-year Anthropic lease for roughly 401 MW at the Justified Data Campus worth about $19bn over the initial term, multiple Fluidstack deals backstopped by Google credit and warrants, total contracted revenue above $27bn across roughly 839 MW, and projected run-rate rent near $1.76bn at full delivery. Muskie contracted power doubled to 1 GW with the second 500 MW phase moved to 2029, and the Kentucky PSC approved power for Justified. The author cites consensus targets in the $32–33 range against recent levels near $11–13 and references notes from TD Cowen, Wells Fargo and UBS. Treat the framing as a promotional post.

Rocket Lab down on the Neutron delay, with targets split

Rocket Lab is down 6.6% and this is the most heavily covered name on your list. On October 14 CEO Peter Beck said Neutron's first flight slips to 2027. An inspection found air pockets, or voids, in the forward dome of the first-stage carbon-composite propellant tank, traced to a recent design change that thickened sections for strength and made them harder to cure without trapping air. Beck said the bubbles wouldn't necessarily cause a failure but the tank missed internal safety margins: "Possible success isn't our standard." The manufacturing process has been fixed and validated on a second tank section, and the affected part is being rebuilt. The minimum hit is four months of qualification test and assembly; if key tests pass as early as January, a new date gets set, not before Q2 2027. Beck also said second and third rockets are already in production with upgrades pulled forward. Analysts split on magnitude, not direction: Needham held Buy and $120 while cutting its FY2027 revenue estimate on fewer Neutron flights; Citizens cut to $90 from $130, keeping Market Outperform, with Trevor Walsh noting the stock is down about 21% year-to-date against the aerospace and defence ETF down 7.6% and the Russell 3000 up 12%; KeyBanc cut to $100 from $135, Overweight; Stifel reiterated Buy at $132; Cantor Fitzgerald held Overweight at $122, with Andres Sheppard modelling a Q2 2027 debut and the first revenue-generating launch in Q4 2027. GuruFocus has the stock at $55.25 against a GF Value of $39.14, a GF Score of 77 with growth 10 of 10 and profitability 3 of 10, revenue up 53% year over year, and insider selling of $683.3m over twelve months with no buys. One headline-only item flags notable Thursday option activity in RKLB alongside OLLI and MCD.

Intuit, AST SpaceMobile and Nurix valuation notes

Intuit rose 6.4% to $330.17, but it is down 49.5% year-to-date and 48.7% over twelve months. GuruFocus puts GF Value at $831.99, a GF Score of 82 with profitability and growth both 10 of 10 and valuation and momentum both 2 of 10, a trailing P/E of 20.0x against a five-year median of 58.5x, and forward P/E of 13.9x. Insiders sold a net $357.2m over the past year. AST SpaceMobile is up 5.5% to $44.46 against a 52-week range of $39.87 to $133.86; GuruFocus shows a GF Score of just 44, growth 0 of 10 and profitability 1 of 10, with net insider selling of $450.8m. No company news behind either move in what I have. Nurix is up 5.4%: HC Wainwright kept Buy and raised its target to $36 from $34, with GuruFocus noting GF Value of $54.06 against $24.95 and a GF Score of 65. Separately, CSO Gwenn Hansen sold 1,452 shares at $25.00, total $36,300, under a 10b5-1 plan, having exercised options at $1.86; she still directly owns 117,227 shares. That article also recaps post-Q3 target moves from Stifel to $41 on the Roche collaboration, Morgan Stanley to $38, RBC to $35 and Truist to $33.

Adobe and the Nvidia expansion

Adobe is up 4.6% across several headline-only items saying it expanded its Nvidia partnership to speed up creative tools and agentic creation, with Brand Concierge using Nvidia Nemotron due for enterprise customers later this year. A separate GuruFocus headline asks whether it's too late after the rally, saying GF Value reads undervalued. Accenture is also up 4.6% on a GuruFocus valuation headline citing GF Value of $349.90 against $224.92.

Netflix content chief change

Netflix is up 2.9% with a dense headline-only cluster: Peter Rice, formerly of Disney, named chief content officer as Bajaria departs, alongside reported layoffs. Several of those headlines describe shares dipping or sliding, which sits against today's quoted gain. Rosenblatt stayed Neutral, BMO cut its target citing engagement concerns, and Jefferies assumed coverage with Buy at $85. Another headline notes heavy options activity ahead of earnings.

SpaceX headlines, stock lower

SPCX is down 2.3% despite the heaviest headline flow of any name. Tesla unveiled a redesigned Roadster at a SpaceX facility with SpaceX thrusters and a claimed 0.81-second 0-60. Evercore ISI raised its SPCX target to $275 on compute growth. On the geopolitics, Reuters reported the White House ordered SpaceX to limit Ukraine satellite service, a US official later clarified there are no Trump restrictions on Starshield for Ukraine, and Zelenskiy said there's no discussion of substituting Starlink; European satellite stocks extended a rally on the Starlink curb story. The EU plans to fast-track antitrust approval of a SpaceX rival. Musk also posted about a Star Mind computer co-engineered with Nvidia reaching volume production next year. All headline-only.

Semis, Micron insider filings and TSMC

Micron is up 1.9% on a very large batch of Form 4s dated 13 and 14 October covering CEO Sanjay Mehrotra, CFO Mark Murphy, COO Manish Bhatia and most of the board, plus chief legal officer Michael Ray selling $5.8m of stock. These are headline-only filings, so I can't say what's routine vesting versus discretionary. TSMC is down 1.8% after reporting a record quarter, with headlines describing a sell-off anyway and the CEO saying the gap between demand and supply remains large. Taiwan is reported to be planning a $4bn Texas hub for Nvidia's AI supply chain. Broadcom is down 0.6% on ETF-flow and chart headlines, plus a note that Anthropic secured a BB+ rating from KBRA ahead of a $35bn chip financing deal with another $60bn reportedly being assembled.

Everything else is quiet

The rest is low-signal: Take-Two up 4.0% on GTA VI optimism headlines and a Form 144, UiPath up 5.0% and Red Cat, Beam, Planet Labs and Nebius each with only a Form 144, Comcast up 3.4% and NetApp down 3.4% on GuruFocus valuation screens, TD Synnex down 3.3% with chair Dennis Polk selling $629k, AngloGold up 3.1%, Oracle up 3.0% on ETF buying and valuation headlines, Paychex up 2.2% declaring a $1.19 quarterly dividend, CRISPR up 2.6% with UBS initiating at Neutral and a $52 target, and a long tail of Apple ETF-flow items around the $5trn market cap with Apple itself down 0.3%. Datadog is down 1.1% even as Mizuho raised its target to $330. Nothing there needs a closer look on today's tape.

Datavault AI leads the board on a chart post

DVLT is up 12.2%, and the only item behind it is a TradingView chart post from GNRI_Maker, not news. The author argues DVLT finished a correction at $0.1200 and is in a final ending-diagonal wave with a false breakout, naming $0.4000 to $1.00 as where the stock is free to move. That's one trader's technical read with TradingView's own disclaimer attached, and there's no company announcement in the material to go with the move.

Surf Air signs fifth OperatorOS customer

SRFM is up 10.9% after announcing a definitive agreement with Flying Zebra for its OperatorOS flight operations software, the fifth commercial contract for the platform and enough to meet its stated goal of five operators live by end-2026. Surf Air earns a percentage of revenue on every Flying Zebra trip run through the software; Flying Zebra operates four aircraft. The platform is powered by Palantir, handles aircraft and crew scheduling, flight management and reporting for Part 135 operators, has run Surf Air's own Southern Airways and Mokulele since 2025, and was recently approved by the FAA as an authorized system of record for electronic signatures and recordkeeping. Barrett Brown, president of SurfOS, said getting each signed operator actually onto the platform is the priority. GuruFocus covered the same release with the balance-sheet side: market cap $111 million, P/S around 0.75x against a historical median of 0.5x, no meaningful P/E because the company is still lossmaking and cash-flow negative, GF Score 47/100 with growth at 9/10 but financial strength at 2/10, GF Value of $0.65 versus a $0.83 price, and roughly $0.2 million of insider selling over twelve months with no buys.

Morgan Stanley overweight on TeraWulf

WULF is up 9.2%. Morgan Stanley started it Overweight with a $65 target, which it frames as 392% upside, arguing the recent share price decline is disconnected from contract value. The catalysts cited are a credit backstop tied to the Hawesville project, lease agreements for the Muskie site, cash-generating existing assets and European expansion. GuruFocus's counterweight in the same piece: P/S of 28.2x against a 12.7x median, GF Score 38/100, financial strength and profitability both 2/10, debt-to-equity of 35.56, an Altman Z-Score of -0.8, TTM EPS of -4.4, and insiders selling $36.1 million against $0.4 million of buys over the past year.

Upstart rises despite a target cut

UPST is up 8.7% on a day when the only item is a negative one. Citizens kept its Market Underperform rating and cut the target from $20 to $18. GuruFocus notes the stock at $22.51 against a GF Value of $61.72, a GF Score of 66/100 with growth at 8/10 and valuation at 2/10, P/E of 41x versus a five-year median of 65.25x, and insider activity of $1.28 million of buys against $4.37 million of sales over three months. Worth noting the article dates the Citizens action to October 13, 2023, which looks like a stale date stamp in the piece rather than something I can resolve.

SoundHound at a 52-week low

SOUN shows up 7.9% on the quote, but the article covering it is about the stock touching a new 52-week low of $4.46, trading at $4.45 with a $2.01 billion market cap, 80% below its $22.17 high and down 78.18% over a year. InvestingPro puts Fair Value at $5.04 and flags RSI in oversold territory. The piece also recaps Q2 2026: record revenue of $61.9 million, up 45% year over year and 40% sequentially, with an adjusted loss of $0.02 per share against the $0.12 loss analysts expected. Yorkville Ives started coverage In Line with a $6.50 target. The article doesn't explain today's bounce, so take the low as the reported event and the move as the quote.

Aurora Mobile's GPTBots into Japan

The item tagged AUR, up 6.9%, is actually about Aurora Mobile (NASDAQ: JG), whose GPTBots.ai platform has partnered with Tokyo-listed AI Storm to deploy AI tools in the contact centres of its wholly owned subsidiary Nihon Telesystem. NTS has run contact centres for over 38 years and will use GPTBots to digitise veteran agent knowledge across three stages: AI role-play simulations for training, surfacing information during live calls, and automatic post-call summaries. The framing is "Human-Led AI", support rather than replacement, aimed at Japan's contact-centre labour shortage. The article's own ticker box shows JG down 8.35%, so the quote on your line and the stock in the story don't obviously match.

Rocket Lab's Neutron slips to 2027

RKLB is down 6.7%, and this is the busiest story in the list. An October 14 8-K pushed Neutron's first flight into 2027 with no quarter named. The cause is a manufacturing quality problem: voids, small air pockets between carbon-fibre layers, found in the forward propellant dome of the first-stage tank. An earlier tank failed qualification testing in January, which pushed Rocket Lab to automated fibre placement, and the voids then showed up in thicker sections of the forward dome during curing. Peter Beck says the revised process has already produced a good aft dome. A replacement forward dome is in production, with curing, inspection, first-stage assembly, hydrostatic and cryogenic testing all expected to complete in Q1 2027, after which the company will set a launch date. Beck says the second and third rockets are already in production with upgrades pulled forward. Neutron is designed for up to 13,000 kg to low Earth orbit and is the vehicle meant to take Rocket Lab beyond small-satellite launch.

Analysts split on how much the delay matters

The sell side largely stayed positive while trimming. Stifel reiterated Buy with a $132 target, calling it a manufacturing refinement issue from scaling some of the largest carbon composite structures ever built for a launch vehicle, not a fundamental Neutron problem, and noting demand remains strong, more cash than debt on the balance sheet, and 53% revenue growth over the last twelve months. KeyBanc kept Overweight but cut from $135 to $100. TD Cowen's Gautam Khanna reiterated Buy at $90 on October 9. Cantor's Andres Sheppard held Overweight at $122 and now models a Q2 2027 debut with the first revenue-generating launch in Q4 2027, his estimate rather than a company commitment. Raymond James has Outperform at $80, Berenberg Buy at $83. The Investing.com round-up adds the detail that the CFO had tied positive adjusted EBITDA to a successful Neutron test flight and sold about $9.9 million of stock under a pre-arranged plan in early October, that this is the fourth schedule slip (2024 to 2025 to late 2026 to 2027), and that insiders sold roughly $26.96 million over three months. Shares closed $59.18 on Oct 14, down 13% on the week; GF Value sits at $39.14. Forward consensus in that piece: FY2026 revenue $959.7 million, FY2027 $1.39 billion, with the next report tentatively Nov 16. Headline-only items also flag notable RKLB option activity and Cantor's reiteration.

Intuit, Adobe, Accenture gain on headline-only items

Intuit is up 6.3%, with headlines noting the shares rising amid a mixed market, an acquisition of Sequence for AI revenue management tools, and a GuruFocus valuation piece. Adobe is up 4.6% on an expanded Nvidia partnership, with the Deltaone post saying Brand Concierge with Nvidia Nemotron will be available to enterprise customers later this year. Accenture is also up 4.6%, carrying a cluster of analyst notes: TD Cowen raised to $201, Susquehanna to $230, and Stifel reiterated on an AI growth outlook. These are headline-only, so that's all the detail available.

The other notable decliners

Cognition Therapeutics is down 5.7% alongside an H.C. Wainwright reiteration on a patent grant. OpenWorld is down 5.2% with a term sheet for a $1 billion tokenized AI financing programme and a matching 8-K. Coherent is down 5.1% with a B. Riley target cut to $297. Arista is down 5.0% and appears in market-cap-mover lists with Lam Research. Vertiv is down 3.5% after Mizuho cut to $280. All headline-only.

AI credit stress and the chip tape

A connected thread runs through several of your names today, all headline-only. Oracle is up 3.1% but the headlines around it are about credit: default insurance on its debt at a record, credit default swaps widening across US tech, and FTC subpoenas to Anthropic and OpenAI pushing Oracle credit risk higher. The same driver shows in CoreWeave and Nebius headlines, with Nebius up 1.3% and Dan Ives quoted calling the selloff a buying opportunity. On the semis side, TSMC is down 1.8% despite record Q3 profit, up 69%, and 41.1% revenue growth with a strong Q4 outlook; headlines attribute the stock fall to CFO comments on margin pressure and a broader chip selloff tied to inflation data and rising yields. Needham raised TSM to $560. Micron is up 1.9% with headlines on a chip-sector selloff, Chinese competition and a Taiwan bonus dispute. Apple is down 0.3% on a very long but low-substance list, mostly ETF flow notes, plus headlines that it closed above a $5 trillion market cap and is working with Meta to run the Muse AI model on Macs.

Quieter names

The rest of the list is thin. PayPal is up 1.9% despite BofA resuming coverage at underperform and a Glance agentic commerce partnership. Netflix is up 2.9% ahead of earnings with Jefferies at Buy and an $85 target. Take-Two is up 4.0% on GTA VI headlines, Comcast up 3.4% ahead of its Oct 22 report, Paychex up 2.2% with a $1.19 quarterly dividend. Broadcom, Costco, Credo, Datadog, Teva, Beam and the various ETF-flow entries carry no real movement or substance today.

AI credit stress is the day's driver

The biggest single story across the list is credit, not earnings. Oracle is down 8.8%, and three separate full reads tie it to the same thing: its five-year credit default swap spread widened 26 basis points to a record 288 bps, up from 260 a week earlier. GuruFocus frames this against CoreWeave, whose CDS has blown out past 1,000 bps, an implied 63% chance of default within five years, with its 2032 bonds trading near 78 cents on the dollar at a yield above 16%. The Walter Bloomberg post adds that default insurance costs have also risen for Nvidia, Amazon, Alphabet and Meta, with the core question being whether AI companies can earn enough to service growing debt. A second GuruFocus piece links the move to the FTC issuing subpoenas to Anthropic and OpenAI over AI safety and privacy, and notes Oracle's P/S at 5.34 near a three-year low, debt-to-equity of 2.53, an Altman Z-Score of 1.56, and insider activity over twelve months of $3.5 million bought against $113.2 million sold. Separately, Saxo's note says investors are splitting the AI trade, favouring profitable chipmakers like TSMC, Samsung and ASML over debt-heavy infrastructure names including CoreWeave, Nebius and Oracle, citing CoreWeave's 15% drop Wednesday and a 14% fall in BlackRock's semiconductor ETF over eight sessions.

Nebius caught in the same squeeze

Nebius is down 10.1%, and the Investing.com piece lays out several overlapping causes rather than one. Wednesday's hotter-than-expected September CPI pushed short-term yields up and raised rate-hike expectations, hitting capital-intensive AI infrastructure hardest. CoreWeave's bond yield spike to 15% drew a widely circulated negative comment from Elon Musk, prompting a reassessment of financing risk across the neocloud space. Gartner published a report warning that more than $3.5 trillion of AI infrastructure spending could face impairment by end-2030, singling out neoclouds for their lack of diversified revenue. On top of that, the COO sold 500,000 shares in early October, CRO Marc Boroditsky sold 7,000 on October 12 under a 10b5-1 plan, and Michael Burry is reported to have shifted from a direct short to leveraged puts on the name.

Credo down on no bad news of its own

Credo is down 9.6%, which Mizuho treats as a pullback rather than a problem. The firm reiterated Outperform with a $245 target after meeting CEO Bill Brennan and CFO Dan Fleming at OCP. Credo announced a 1.6T Active Light Cable using µVCSEL at 50m reach, roughly 200 fibers, 30% less power and ten times lighter than AEC, targeting volume deployment in 2027. The µEmitter roadmap includes a 6.4T optical backplane NPO that could ramp in 2027 at 60% lower power than copper, and the supply chain now includes three end users, two leading GPU OEMs and one hyperscaler. Mizuho sees ZFO and NPO work with DustPhotonics and SPCX driving more than $600 million of optical revenue in fiscal 2027, against 67% gross margin and 165% revenue growth. The article also notes Stifel kept a Buy while cutting its target from $350 to $310 on valuation, and that Mizuho had earlier cut from $290 to $245.

Rocket Lab slips Neutron to 2027

Rocket Lab is down 7.8% after disclosing in an 8-K filed October 14 that the first Neutron launch moves into 2027 from a fourth-quarter 2026 target. Engineers found voids, small air pockets, in the carbon-composite forward dome of the first-stage propellant tank, requiring a redesign and process changes. CFO Adam Spice had previously said a successful Neutron test flight was the trigger for turning adjusted EBITDA positive the following quarter, and he sold roughly $9.9 million of stock under a pre-arranged plan in early October. Cantor Fitzgerald kept Overweight and a $122 target, with analyst Andres Sheppard now modelling first launch in Q2 2027 and first revenue-generating launch in Q4 2027, calling the delay disappointing but not material long term. TD Cowen had already trimmed to $90 from $120 earlier this month. The stock is more than 60% below its $151 52-week high on a six-day losing streak.

Surf Air signs its fifth OperatorOS deal

Surf Air Mobility is down 6.3% despite announcing a definitive agreement with Flying Zebra, a four-aircraft operator, for its OperatorOS flight operations software, built on Palantir. It is the fifth commercial OperatorOS contract and goes toward the stated goal of five operators live by end-2026, with Surf Air earning a percentage of revenue on trips run through the platform. The FAA recently approved the software as an authorised system of record for electronic signatures and recordkeeping. The article gives no reason for the share price move.

TSMC: record quarter, stock still lower

TSMC is down 3.4% on a heavy run of headline-only items. Per those headlines, Q3 revenue rose 50.9% to NT$1.49 trillion, net income 68.7% to NT$763.1 billion, EPS NT$29.43, gross margin 66.4% and operating margin 58.7%. Advanced nodes at 7nm and below were 79% of wafer revenue, with 2nm at 8% from 3% the prior quarter, and HPC at 68% of revenue versus 57% a year ago while smartphones fell to 21%. The CFO said 2026–2028 capex will be significantly higher than the past three years, and the CEO said he sees no sign of an AI demand slowdown and no intention to leave business on the table. Several headlines note the stock fell anyway, and one mentions a Texas fab under consideration.

Rest of the semis and the smaller names

The chip complex moved with the same rate-driven selloff: Micron down 4.1%, SanDisk down 5.3%, Broadcom down 3.1%, all headline-only. Micron headlines cite the sector sell-off on rising borrowing costs and AI spending, Chinese competition in memory, and a bonus dispute with a strike threat in Taiwan that the president has urged the company to resolve. One headline reports Anthropic's quarterly revenue rose 45% to $16.8 billion, a sharp slowdown from triple-digit growth, feeding the AI selloff, with another headline saying Anthropic is profitable again. Elsewhere, Citizens cut its Upstart target to $18 on bank charter concerns, with UPST down 4.6%. Goldgroup Mining invested C$101 million in Luca Mining, with GORO down 4.5%. KeyBanc downgraded Cirrus Logic on Apple concerns, and Apple itself closed above a $5 trillion market cap and is up 0.5%, against a headline saying global smartphone shipments fell 22% in Q3 on rising storage costs. Jefferies assumed Netflix with a Buy and an $85 target, BofA resumed PayPal at Underperform, and TD Cowen raised Accenture to $201 on its AI growth outlook. Costco is up 2.9% with nothing behind it but an ETF flow note and a chart post.

Movers with no story attached

Several names moved on nothing in this list. Modine is down 8.6% but only appears as a background holding in four GuruFocus 13F write-ups about other companies. NetApp is down 7.0% and shows up only as a line in an Invesco equal-weight ETF rebalancing piece. CAN is down 7.6% tagged to a Walter Bloomberg headline about France cutting its deficit to 3% in three years, which has nothing to do with the stock. SpaceX is down 2.8% across a batch of headlines covering Starlink restrictions for Ukraine's military, United expanding Starlink to half its flights, and a Barclays view that a Tesla-SpaceX merger could be announced before Tesla's annual meeting. The long tail of Dimensional, JPMorgan and Millennium 13F filings tagged to AAPL and SPCX is filing noise, not news about those names.

Hot CPI and an AI credit scare set the tape

The day's losses on your list are mostly one story. September CPI came in at 3.7% headline against 3.6% expected and 2.6% core against 2.5%, and the Nasdaq closed down 1.85% with the VIX up 10.5%. On top of that, the AI infrastructure complex got a credit scare: the Financial Times reported the yield on a CoreWeave bond maturing in 2032 hit nearly 15% on Tuesday, about 1.5 points higher over a week. CoreWeave has raised more than $35 billion this year and carried roughly $52 billion in debt and lease obligations at the end of June, with Q2 interest costs more than doubling to $640 million and debt around 5.8x annualised Q2 EBITDA. CreditSights analyst Jordan Chalfin told the FT the bonds sold off on fears its long data center leases outlast its shorter customer contracts: "If there's an overbuild, why would [customers] renew their contract with CoreWeave?" Visible Alpha consensus is about $25 billion of negative free cash flow this year. CoreWeave reports November 11.

RNTX down 23.7% with nothing behind it

Rein Therapeutics was the biggest fall on the list, down 23.7% to $0.5776 on 716,000 shares against a 421,000 average, closing at a new 52-week low. Nothing in the material explains it. The company is a 10-employee biopharma with LTI-03 in Phase 2 for idiopathic pulmonary fibrosis, $40.65 million of cash against a $49.8 million market cap and a trailing loss of $49.8 million. The last analyst action on file is HC Wainwright reiterating Buy with an $8 target back in August.

Neocloud and bitcoin-miner names take the brunt

Nebius fell 10.1%, called out alongside CoreWeave as the steepest Nasdaq 100 decliners. Two separate GuruFocus pieces tried to pin it on an insider sale and found little: the October 13 filing shows chief revenue officer Marc Boroditsky exercising 7,000 options at $40 and selling at $211.23 for $1,478,610 gross, under a trading plan adopted June 15, with 336,000 options still outstanding. Nebius raised more than $2 billion in a stock offering earlier this year. TeraWulf dropped 12.5% to $11.55 on 49.7 million shares versus a 30.3 million average, and the whole peer group moved together, Cipher -12.5%, IREN -12.3%, Core Scientific -12.5%, Hut 8 -10.5%. Nothing company-specific on WULF; Morgan Stanley actually raised its target to $65 from $62.50 on October 12 keeping Overweight.

VNET and XMTR fall hard without an explanation

VNET lost 14.9% to $4.4999, a new 52-week low against a $14.48 high, on volume slightly below average. The Yahoo page carries no news behind it, just the fundamentals: trailing revenue of 10.74 billion, a trailing net loss of 2.38 billion, debt/equity above 309%, and a consensus one-year target of $13.64. Xometry was down 12.0%, trading near $96 intraday against a $112.94 52-week high, also with no item explaining it and volume roughly in line with its average. The stock is still up about 62% year to date, and Rosenblatt raised its target to $120 from $110 in September.

ASTS downgraded by Piper Sandler

AST SpaceMobile fell 10.5%. Piper Sandler cut it from Overweight to Neutral and took the target to $54 from $98, a 44.9% reduction, on satellite-launch concerns. The economics in the article: June-quarter revenue of $31.5 million from gateway deliveries and government milestones against $119.1 million of adjusted operating expenses, roughly 3.8 times sales, with about $2.7 billion in cash, equivalents and restricted cash at June 30. Insiders sold $451.6 million of stock over the past twelve months against $0.8 million bought. A second GuruFocus item flags a GF Value of $583 versus the $47 price, but the piece itself calls that an extreme reading rather than a fair-value target given the company is unprofitable, and labels it a possible value trap.

Power and optics names caught in the same downdraft

Forgent Power Solutions fell 9.8% to $32.90, with JP Morgan having cut its target to $49 from $56 on October 9 while keeping Overweight; no fresh news. Coherent was down 9.3%, with the only item a GuruFocus DCF putting earnings-based intrinsic value at $52 against a $290 price, noting the stock is still up 57% year to date and 152% over the year, and that insiders sold $1.117 billion of stock over twelve months. NuScale Power fell 9.9%, with a headline-only Nasdaq piece simply noting it is now technically oversold. Vicor -8.2%, Astera Labs -7.8%, Generac -7.6% and Vertiv -6.2% round out the group; on Vertiv the only substance is a headline that RBC lowered its target to $323, and unusual option activity.

Oracle down 9% with Project Jupiter in focus

Oracle lost 9.0% to $130.54, now 56% below where it was a year ago and well off its $322.54 52-week high. Mizuho reiterated Outperform with a $320 target after attending a Doña Ana County Commission meeting where Oracle updated construction progress on Project Jupiter and discussed power infrastructure and regulatory hurdles. Oracle renewed its request for expedited FERC approval of the Green Chile pipeline, and Mizuho's clean energy team heard from a former BLM New Mexico State Director that the proposed pipeline reroute could avoid restarting environmental review. Mizuho sees no impact to FY2027 estimates. Investor Day is October 28. Separately, NetSuite launched QuickStart, a free accounting, AR/AP and subscription-management platform for eligible early-stage US tech startups with an AI assistant called Ask Oracle and usage caps including 2,500 records a month and four connected bank accounts.

Storage, memory and semis

NetApp fell 7.1% on a Barclays downgrade to Equal-Weight, part of a note that also cut HPE and Dell on enterprise AI spending trends; Dell was down 11.4% on the day. SanDisk fell 5.3% with a cluster of TradingView commentary centred on Chinese NAND competition, and Micron was down 3.9% despite headlines about a $35 billion buyback and a note that Micron and Nvidia together are expected to supply 9.8 points of the S&P 500's projected 27.2% Q3 earnings growth. TSMC fell 3.3% ahead of Thursday's results. Broadcom fell 3.1%, and the one piece of substance there is the CEO's warning that enterprise AI spending is still too experimental and often lacks measurable returns, comparing it to a kid burning through $10 of arcade tokens in ten minutes.

Netflix cutting 6% of staff

Netflix was essentially flat on the day, up 0.2%, but the news flow is heavy: around 1,000 job cuts, about 6% of the workforce, its biggest layoff since 2022, a week before earnings, with the stock down roughly 40% over the past year. Several items tie it to slowing growth and rising US churn, and one quotes the co-CEO from earlier this month saying the company is not growing as fast as he wants.

The green side

Little of size. Nurix was the best gainer at +6.8%, on a headline-only SWOT piece drawn from its 10-Q citing financial challenges alongside the pipeline. Intuit +3.0% and Axsome +3.7% on an RBC reiteration, Incyte +2.8% with Truist raising to $115, Revolution Medicines +2.8% with RBC raising to $260 and an 8-K on a new financial obligation, Costco +2.9%, Marathon Petroleum +1.6% with target raises from Wells Fargo to $560 and Citigroup to $518, and Accenture +0.7% after an investor day where it gave guidance the coverage described as strong. All headline-only.

OpenWorld drops on an amended filing

OpenWorld is down 16.1%, the largest move on the list, against a headline-only item: an 8-K/A on EDGAR covering Item 9.01, financial statements and exhibits. Nothing in the material explains the size of the move.

Nutriband funds the AVERSA patch

Nutriband is up 11.5% after announcing on October 13 that it raised $1.75 million through the exercise of 272,671 NTRBW warrants at $6.43 per share, which cleared out all remaining tradeable warrants following their September 30 expiration. The money is earmarked for clinical development and the FDA submission of AVERSA, its abuse-deterrent fentanyl patch, which the article says could generate $80 million to $200 million in annual US sales if approved. The GuruFocus piece around it flags the company's price-to-sales ratio at 43.65 against a historical median near 28.4, an Altman Z-Score of 36.61 and debt-to-equity of 0.04, a GF Score of 52 out of 100, and a GF Value estimate of $2.87 per share. Market cap is $71 million, and the company remains unprofitable with an operating margin worse than -435%.

AST SpaceMobile downgraded on SpaceX launch risk

AST SpaceMobile fell 8.5%, and six separate items all trace to one cause: Piper Sandler's Alexander Potter cut the stock from Overweight to Neutral and took his target from $98 to $54, roughly a 45% reduction. His reasoning is lower conviction on the pace of AST's 2026 and 2027 satellite launches, driven by SpaceX's push into direct-to-cell, including its roughly $8 billion commitment to acquire mobile spectrum. Piper's view is that SpaceX could in theory restrict launch availability for carrier-aligned partners like AST, undercut pricing, or bring its own devices. One of the write-ups says Piper now models only 18 operational satellites by end-2026 against a prior 45, pushing commercial service into the second half of 2027. Piper kept a constructive longer-term stance past 2027, arguing SpaceX's aggression raises carrier urgency to partner with an independent provider. For context the articles cite: June-quarter revenue of $31.5 million against $119.1 million in adjusted operating expenses, about $2.7 billion in cash, cash equivalents and restricted cash at June 30, a GF Score of 44/100, and insider net selling of about $450.8 million over the past twelve months. Next earnings are mid-November. The GuruFocus valuation piece notes the stock sits in a 52-week range of $47.57 to $133.86, down 25.4% on the week and 35.2% year to date, and labels it a possible value trap despite a GF Value of $583.31.

SpaceX itself down on Starlink and Ukraine headlines

SpaceX is down 4.2%, and the headline-only items on it point in two directions at once. Several concern Starlink limitations affecting Ukraine's ability to down Russian drones, with Kyiv said to be in contact with the US, SpaceX and NATO for clarification. Separately, Morgan Stanley's Adam Jonas reiterated Overweight with a $300 target, citing a Distributed Inference Cloud as an overlooked growth driver, and there are headlines on an FAA request for more Starship launches at the South Texas site, a United Airlines Starlink fleet rollout, and ETF net selling on October 12. These are headlines only, so there's no detail behind them beyond what they state.

Axsome sold off, RBC defends

Axsome is down 5.8%. RBC Capital reiterated Outperform with a $295 target, noting the stock has fallen roughly 28% over the past month against a 6% decline in the XBI, which the firm attributes to weaker-than-expected prescription trends. RBC argues those trends reflect seasonality and sampling dynamics rather than launch weakness, says the shares now trade about 15% below where they were before the Alzheimer's agitation approval, and continues to model a $2.3 billion agitation opportunity in 2035. The article notes the stock at $156.32, down 14% year to date. It also recaps recent coverage: Q2 2026 revenue of $218.4 million against H.C. Wainwright's $211.1 million estimate, a net loss of $0.99 per share, Mizuho at $316, H.C. Wainwright at $290, and Truist initiating at Buy with $285.

Cognition and Codexis both down 6.4%

Cognition Therapeutics closed at $0.8017, down 6.44%, on volume of 3.73 million shares against a 520,740 average. The Yahoo page shows no news driving it, just the price data, a 52-week range of $0.55 to $2.00, $34.01 million in cash and a trailing net loss of $16.77 million. Codexis is down 6.38% alongside a Form 144 filing notice dated October 14, which is a proposed-sale notice; the item carries no detail on size or seller.

Navitas up on nothing in particular

Navitas rose 4.6% to $10.45. The only item is a GuruFocus valuation piece with no news hook, which notes a GF Value of $3.01 against that price, a GF Score of 63/100, a 52-week range of $6.85 to $34.17, and insider selling of $150.7 million over twelve months with no buying.

Oracle up 4.2% on Project Jupiter and a product launch

Oracle gained 4.2% to $143.20 with several items behind it. The most substantive: Oracle has renewed its push for FERC to expedite approval of the 17.8-mile Green Chile pipeline, which would carry about 400 million cubic feet of gas a day to power the Project Jupiter data center campus in New Mexico via Bloom Energy fuel cells and an off-grid microgrid. The pipeline's timeline has already slipped to February 2027 from an initial August target after local opposition forced Transwestern, an Energy Transfer subsidiary, to reroute onto federal land. Environmental groups and New Mexico Attorney General Raúl Torrez want FERC to widen its review to cover the data center and pipeline together. Oracle told FERC the four-building campus should support nearly 5,800 peak construction jobs and up to $1.1 billion in annual economic output for Doña Ana County. Mizuho reiterated Outperform with a $320 target after attending the Doña Ana County Commission meeting, said regulatory approvals are still outstanding but kept a constructive view, and sees no impact to FY2027 estimates. Oracle's Investor Day is October 28. Separately, Oracle NetSuite launched QuickStart, a free financial platform for eligible early-stage US tech startups with accounting, banking, AR/AP and subscription management, an AI assistant called Ask Oracle, Claude and ChatGPT connectivity via Model Context Protocol, and built-in MRR, burn and runway metrics, with usage caps including 2,500 new records and 800 emails per month. A Deutsche Bank note groups Oracle with Alphabet, Amazon, Meta and Microsoft as spending nearly $800 billion in capex this year, with annual spending potentially above $1 trillion through 2030, and raises the risk of an "AI air pocket" where spending precedes revenue. Headline-only items add a Marvell/Microsoft/Oracle security working group and rising implied volatility in Oracle options.

Memory and semis under pressure

Micron is down 3.6% with a cluster of headline-only items, including a reported $35 billion buyback announcement, a broad memory and storage selloff, and various technical pieces. SanDisk is only down 0.3% on the main listing despite a heavy volume of commentary, though a separate chart item flags the Toronto line down 9.7%. Arista is down 3.0%, with headlines noting CEO Jayshree Ullal sold $34.4 million in stock and option activity. These are headline-only, so there's no reasoning behind them beyond what each line states.

Refiners and the rest

Marathon Petroleum rose 4.0% and headlines note an all-time high and a Citigroup price target raised to $518. Take-Two is down 4.1% and Xenon down 3.9%, both on headline-only items with no stated cause. Everything else on the list is inside two percent, including Apple at +0.1% despite a long run of HomeView smart display headlines, Netflix at -0.2% with a Huber Research double downgrade and Spain 2030 World Cup rights both in headlines, and TSMC at +0.2% ahead of Thursday earnings. Nothing there needs a second look today.

VerifyMe/OPNW down 17.3% on no visible news

OPNW was the biggest mover on the list, down 17.3%, but the two items attached to it are bare Form 4 filings for VerifyMe insiders Gerard Hernandez (Chief Accounting Officer) and CEO Matthew Shaw, both dated 30 September. The Investing.com pages carry nothing beyond the filing titles, no share counts, prices or transaction types. So there's no stated explanation here for the drop, and if you want one you'd need to go to the filings themselves.

Nutriband warrant cash

Nutriband rose 12.7%. The company said on 13 October it raised $1.75 million by exercising 272,671 NTRBW warrants at $6.43, which clears out all remaining tradeable warrants after their 30 September expiry. The money goes to clinical development and the FDA submission for AVERSA, its abuse-deterrent fentanyl patch, which GuruFocus notes could carry $80m to $200m in annual US sales if approved. The same piece flags the other side: price-to-sales of 43.65 against a 28.4 historical median, no meaningful P/E on negative earnings, operating margin worse than -435%, GF Score 52/100, though balance sheet strength is good with an Altman Z of 36.61 and debt-to-equity of 0.04. Market cap $71 million.

AST SpaceMobile downgrade, SpaceX the cause

ASTS fell 8.4%, and five separate items all trace to one note. Piper Sandler's Alexander Potter cut the stock from Overweight to Neutral and the target from $98 to $54. His reason is reduced conviction on the pace of satellite launches in 2026 and 2027, driven by SpaceX's direct-to-cell push, specifically Friday's roughly $8 billion commitment to buy mobile spectrum. Potter's argument is that SpaceX could restrict launch availability for carrier-aligned partners like AST, undercut mobile operator pricing, or bring out its own devices. GuruFocus adds the detail that Piper now models just 18 operational satellites by end-2026 versus a prior 45, pushing commercial launch into the second half of 2027. Piper stayed constructive beyond 2027 on the view that SpaceX aggression raises carrier demand for an independent provider. Context in the same coverage: the stock was at $51.46, 62% off its $133.86 high and down 18% on the week, with targets across the street spanning $42.50 to $108. Recent contrary calls include Deutsche Bank's upgrade to Buy at $93 on spectrum value and Berenberg initiating Buy at $92, against B.Riley cutting to Neutral at $65 and William Blair trimming its 2027 revenue estimate to $459m from $752m on launch delays. Insider selling at ASTS has been heavy, $451.6m sold against $0.8m bought over twelve months.

SpaceX itself off 4.1%

SPCX fell 4.1% on a crowded but headline-only feed: an FAA application for more Starship launches at the South Texas site, a CRS-35 launch, United expanding Starlink to its 737 MAX 8 fleet with completion expected before end-2027, Bernstein downgrading AT&T on Starlink competition, Amazon's satellite internet plan, an X/Grok subscription repriced from $90 to $30 a month, and $91.5m of ETF buying on Friday. None of these were read in full, and none is identified as the reason for today's move.

Cognition Therapeutics falls despite patent grant

CGTX was down 6.6% even though the news of the day was positive. The USPTO granted US Patent No. 12,759,979 covering a crystalline polymorph of zervimesine, its lead candidate, plus the production process and methods of treating Alzheimer's, dry AMD and dementia with Lewy bodies. Natural expiry 2045, with up to five years of possible extension on FDA approval. CMO Anthony Caggiano said the form has a better pharmaceutical and physiochemical profile suited to Phase 3-scale manufacturing. The company meets the FDA next week to settle endpoints for its registrational DLB programme and plans to start manufacturing the new form in Q1 2027 if that goes well. The articles don't say why the stock fell; the Yahoo chart item shows volume at 5 times the 20-day average and a 14.9% drop over five days.

Planet Labs insider sale and valuation flag

PL was down 5.1%. Director Ita Brennan sold 11,500 Class A shares on 1 October at a weighted average $16.3025, $187,478 in total, under a 10b5-1 plan adopted in January; she retains 250,373 shares. The stock has since gone to $15.96, down 14% on the week and 53.5% over six months. Background in the same piece: fiscal Q2 2027 came in at $116.1m revenue and adjusted EPS of $0.02 against expectations of $104.54m and a $0.02 loss, up 58% year over year on defence and intelligence demand plus a satellite-services handover, but Q3 guidance landed 10% below consensus. Needham cut its target to $40 from $53 on revenue timing while keeping Buy. A separate GuruFocus note on the prior session's 7.1% fall puts GF Value at $5.64 versus the $15.96 price, and counts $46.8m of insider selling over twelve months with no buying.

Navitas up on second Nvidia power board

NVTS rose 4.9%. It announced a 24 kW power delivery board converting 800 VDC straight to 12 VDC in a single stage, cutting out the 50 V intermediate bus converter, developed with Nvidia for the MGX ecosystem. Targets are 97% efficiency at full load and density above 2,000 W/in³ in a 400 mm by 60 mm form factor, using 16 NV6034 GaNFast FETs in a stacked half-bridge. It follows an earlier 20 kW, 800 V-to-6 V board also done with Nvidia, and will be shown at OCP Global Summit 2026. GuruFocus notes P/S of 61.67 against an 18.4 median, GF Score 63/100, EPS of -1.33, and $150.7m of insider selling over the past year with no buying.

Oracle and the AI capex question

ORCL gained 4.4%. The substantive piece is Deutsche Bank's AI research note, which puts Alphabet, Amazon, Meta, Microsoft and Oracle on course for nearly $800bn of capex this year and possibly over $1 trillion annually through 2030. It estimates an AGI-scale training run could need $300bn to $500bn of infrastructure and about 6 GW of power, or roughly 7.8 million Vera Rubin chips and 26 GW if compressed into four months, around $900bn at today's prices, possibly $200bn by 2030 on efficiency gains. The bank also points out the investment case doesn't need superintelligence: enterprise AI adoption is running about three times faster than the mobile, internet and cloud waves, with non-China AI revenue possibly above $200bn in 2026 against under $1bn in 2022. The risk it flags is funding on expected rather than earned revenue, what DeepMind's Jasjeet Sekhon calls an "AI air pocket." Separately and headline-only, Marvell, Microsoft and Oracle have formed a security working group, and there's a note on rising implied volatility in Oracle options.

Memory and semis sold off

The chip complex was the day's shared drag. MU fell 3.7%, with a cluster of headlines including a flagged sector-wide selloff listing Western Digital -6.5%, Seagate -6.1%, SK Hynix -4.8%, Micron -4.7% and SanDisk -4.1%, plus Cathie Wood flagging memory chip risks and a buyback authorisation lifted to $35.16bn. ANET was off 3.1%, with a chart item showing a 5.4% move at 1.7 times its own ATR20 on below-average volume. SNDK was roughly flat at -0.3% despite the noise, and had an S&P upgrade to BBB on AI memory demand. AVGO was up 0.8% and TSM up 0.2%. TSEM rose 2.6% on a headline about expanded SiGe capacity with Semtech. All of these are headline-only.

Quieter names worth a glance

Marathon Petroleum rose 4.1% and headlines note an all-time high at $470.42 and a Barclays target raised to $488. Take-Two fell 4.0%, with nothing attached beyond a chart item showing the move at 1.9 times its ATR20. Xenon Pharmaceuticals hit a 52-week low at $35.04, down 3.7%. Rocket Lab was off 2.2% with CFO Adam Spice selling $9.9m of stock. Adobe slipped 0.8% after HSBC downgraded it on open-source and AI competition, target cut to $267. Netflix was essentially flat at -0.2% despite a busy feed: a double downgrade at Huber Research on engagement and pricing, a KeyBanc target cut to $85, and exclusive FIFA 2030 World Cup rights in Spain and Andorra. Apple was flat at +0.1% on a long run of HomeView smart display and Apple TV 4K launch items plus a JP Morgan target raise to $360. Everything else on the list moved under 3% and carries routine filings, ETF flow notes and maintained ratings.